Impact of the COVID-19 Pandemic on the Health Status of People Aged 75 and Over and Their Caregivers

NCT ID: NCT05249868

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1035 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-01

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The measures to control the transmissibility of the Covid-19 pandemic have changed the daily routines of the population, increasing sedentary lifestyles, decreasing outdoor physical activity and limiting contact with neighbors, family and friends. This could be having negative consequences for the health of vulnerable people.

The investigators want to know how this situation has affected the health of people aged 75 years or older and their caregivers and how the circumstances experienced may mark new care needs.

To this end, will be analyzed clinical data, follow up people who have become ill with COVID-19 and those who have not, and interview groups of caregivers and patients to hear about the personal impact of the pandemic on them.

This will allow us to explore what changes are needed in health care to achieve an improvement in the health and quality of life of this population.

CUIDAMOS+75 seeks the commitment of the population and of the different people in charge of the health services from the very beginning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective:

To explore the impact of the pandemic SARS-CoV-2 on the state of health of people aged ≥75 years.

Design:

Mixed-methods study. 1) Multipurpose, ambispective, longitudinal population-based cohort study with real world data and 6 years of follow-up; 2) Prospective observational cohort study with 18 months of follow-up; 3) Qualitative study with a critical-social approach. Scope:

Primary care in 11 Autonomous Regions.

Population:

People aged ≥75 years, attending healthcare centres in the study area.

Sample:

The population cohort will include the total population that meets the criteria, out of the estimated 1619620. The prospective cohort size is 1035, recruited on a probabilistic basis by clinical nurses. In the social critical approach the selection will be intentional and will progress towards theoretical sampling according to the emerging findings.

V. outcome:

Population-based cohort: nursing diagnostic and interventions and use of services; mortality, quality of life (EQ-5D) and functional capacity (Barthel) for cohort follow-up.

V. exposure:

SARS-CoV-2 infection.

Sources:

Clinical history, clinical interview, semi-structured interviews and focus groups.

Analysis:

Population cohort: to explore the evolution of diagnostic and interventions, a time series analysis will be carried out. Cohort study: Kaplan-Meier survival curves for mortality, functional change and quality of life. Cox proportional hazards models will be used to study the impact of infection on the three variables at 6, 12 and 18 months, adjusted for socio-demographic and clinical variables. Qualitative study: thematic, semiotic and discursive positions analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging SARS-CoV-2 Infection Caregivers Frailty Burden, Caregiver

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SARS-CoV-2 Infection

Confirmed SARS-CoV-2 infection diagnosed after 11 May 2020 and registered in electronic health records.

(positive confirmatory test on nucleic acid amplification (rRT-PCR) or having had symptoms for \<5 days is positive on a PRAg test)

Exposure SARS-CoV-2 Infection

Intervention Type OTHER

The exposure variable is confirmed SARS-CoV-2 infection with diagnosis after 11 May 2020.

Positive confirmatory test on nucleic acid amplification (rRT-PCR) or having had symptoms for \<5 days is positive on a PRAg test.

NO SARS-CoV-2 Infection

No confirmed SARS-CoV-2 infection with diagnosis after 11 May 2020.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exposure SARS-CoV-2 Infection

The exposure variable is confirmed SARS-CoV-2 infection with diagnosis after 11 May 2020.

Positive confirmatory test on nucleic acid amplification (rRT-PCR) or having had symptoms for \<5 days is positive on a PRAg test.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have at least one entry in the electronic medical record during 2018 (Sub-study 1).
* Have at least one entry in the clinical history during the last 6 months of 2019 (Sub-study 2).
* Give informed consent (Sub-study 2 \& 3).
* Family caregivers of dependent persons included in the population cohort (Sub-study 3).

Exclusion Criteria

* Not belonging to National Health System centres in the territorial demarcations participating in the study (Sub-study 1).
* Not belonging to the quotas of the 105 participating nurses (Sub-study 2 \& 3).
* Carers who have been caring for less than 6 months at the start of the pandemic, with sensory or cognitive deficits (Sub-study 3).
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Salud Carlos III

OTHER_GOV

Sponsor Role collaborator

Hospital del Mar Research Institute (IMIM)

OTHER

Sponsor Role collaborator

Fundación para la Investigación e Innovación Biosanitaria de la Comunidad de Madrid

UNKNOWN

Sponsor Role collaborator

Gerencia de Atención Primaria, Madrid

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Milagros Rico Blazquez

Principal researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Milagros Rico-Blázquez, Master

Role: STUDY_DIRECTOR

Gerencia Asistencial de Atención Primaria de Madrid

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Milagros Rico-Blazquez

Madrid, Madrid, Spain

Site Status

Milagros Rico-Blázquez

Madrid, Madrid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Alfano V, Ercolano S. The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis. Appl Health Econ Health Policy. 2020 Aug;18(4):509-517. doi: 10.1007/s40258-020-00596-3.

Reference Type BACKGROUND
PMID: 32495067 (View on PubMed)

Borges-Machado F, Barros D, Ribeiro O, Carvalho J. The Effects of COVID-19 Home Confinement in Dementia Care: Physical and Cognitive Decline, Severe Neuropsychiatric Symptoms and Increased Caregiving Burden. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520976720. doi: 10.1177/1533317520976720.

Reference Type BACKGROUND
PMID: 33295781 (View on PubMed)

Brown EE, Kumar S, Rajji TK, Pollock BG, Mulsant BH. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias. Am J Geriatr Psychiatry. 2020 Jul;28(7):712-721. doi: 10.1016/j.jagp.2020.04.010. Epub 2020 Apr 18.

Reference Type BACKGROUND
PMID: 32331845 (View on PubMed)

Cohen G, Russo MJ, Campos JA, Allegri RF. Living with dementia: increased level of caregiver stress in times of COVID-19. Int Psychogeriatr. 2020 Nov;32(11):1377-1381. doi: 10.1017/S1041610220001593. Epub 2020 Jul 30.

Reference Type BACKGROUND
PMID: 32729446 (View on PubMed)

Company-Sancho MC, Estupinan-Ramirez M, Sanchez-Janariz H, Tristancho-Ajamil R. The connection between nursing diagnosis and the use of healthcare resources. Enferm Clin. 2017 Jul-Aug;27(4):214-221. doi: 10.1016/j.enfcli.2017.04.002. Epub 2017 May 10. English, Spanish.

Reference Type BACKGROUND
PMID: 28501464 (View on PubMed)

Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):779-788. doi: 10.1016/j.dsx.2020.05.035. Epub 2020 May 27.

Reference Type BACKGROUND
PMID: 32526627 (View on PubMed)

Freijomil-Vazquez C, Gastaldo D, Coronado C, Movilla-Fernandez MJ. When risk becomes illness: The personal and social consequences of cervical intraepithelial neoplasia medical surveillance. PLoS One. 2019 Dec 16;14(12):e0226261. doi: 10.1371/journal.pone.0226261. eCollection 2019.

Reference Type BACKGROUND
PMID: 31841543 (View on PubMed)

Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci. 2015 Mar;10(2):227-37. doi: 10.1177/1745691614568352.

Reference Type BACKGROUND
PMID: 25910392 (View on PubMed)

Johnson VR, Jacobson KL, Gazmararian JA, Blake SC. Does social support help limited-literacy patients with medication adherence? A mixed methods study of patients in the Pharmacy Intervention for Limited Literacy (PILL) study. Patient Educ Couns. 2010 Apr;79(1):14-24. doi: 10.1016/j.pec.2009.07.002. Epub 2009 Aug 3.

Reference Type BACKGROUND
PMID: 19647967 (View on PubMed)

Lam K, Lu AD, Shi Y, Covinsky KE. Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic. JAMA Intern Med. 2020 Oct 1;180(10):1389-1391. doi: 10.1001/jamainternmed.2020.2671.

Reference Type BACKGROUND
PMID: 32744593 (View on PubMed)

Lamont RA, Nelis SM, Quinn C, Clare L. Social Support and Attitudes to Aging in Later Life. Int J Aging Hum Dev. 2017 Jan;84(2):109-125. doi: 10.1177/0091415016668351. Epub 2016 Sep 20.

Reference Type BACKGROUND
PMID: 27655953 (View on PubMed)

Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: Evidence from the field. J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135. doi: 10.1093/jamia/ocaa072.

Reference Type BACKGROUND
PMID: 32324855 (View on PubMed)

Mowbray H. In Beijing, coronavirus 2019-nCoV has created a siege mentality. BMJ. 2020 Feb 7;368:m516. doi: 10.1136/bmj.m516. No abstract available.

Reference Type BACKGROUND
PMID: 32033967 (View on PubMed)

Perez-Rodrigo C, Gianzo Citores M, Hervas Barbara G, Ruiz-Litago F, Casis Saenz L, Arija V, Lopez-Sobaler AM, Martinez de Victoria E, Ortega RM, Partearroyo T, Quiles-Izquierdo J, Ribas-Barba L, Rodriguez-Martin A, Salvador Castell G, Tur JA, Varela-Moreiras G, Serra-Majem L, Aranceta-Bartrina J. Patterns of Change in Dietary Habits and Physical Activity during Lockdown in Spain Due to the COVID-19 Pandemic. Nutrients. 2021 Jan 21;13(2):300. doi: 10.3390/nu13020300.

Reference Type BACKGROUND
PMID: 33494314 (View on PubMed)

Roschel H, Artioli GG, Gualano B. Risk of Increased Physical Inactivity During COVID-19 Outbreak in Older People: A Call for Actions. J Am Geriatr Soc. 2020 Jun;68(6):1126-1128. doi: 10.1111/jgs.16550. Epub 2020 May 14. No abstract available.

Reference Type BACKGROUND
PMID: 32392620 (View on PubMed)

Saltzman LY, Pat-Horenczyk R, Lombe M, Weltman A, Ziv Y, McNamara T, Takeuchi D, Brom D. Post-combat adaptation: improving social support and reaching constructive growth. Anxiety Stress Coping. 2018 Jul;31(4):418-430. doi: 10.1080/10615806.2018.1454740. Epub 2018 Apr 12.

Reference Type BACKGROUND
PMID: 29649912 (View on PubMed)

Saltzman LY, Hansel TC, Bordnick PS. Loneliness, isolation, and social support factors in post-COVID-19 mental health. Psychol Trauma. 2020 Aug;12(S1):S55-S57. doi: 10.1037/tra0000703. Epub 2020 Jun 18.

Reference Type BACKGROUND
PMID: 32551762 (View on PubMed)

Rico-Blazquez M, Esteban-Sepulveda S, Sanchez-Ruano R, Aritztegui-Echenique AM, Artigues-Barbera EM, Brito-Brito PR, Casado-Ramirez E, Cidoncha-Moreno MA, Fabregat-Julve MI, Feria-Raposo I, Hernandez-Pascual M, Lozano-Hernandez C, Moreno-Casbas MT, Otones-Reyes P, Palmar-Santos AM, Pedraz-Marcos A, Romero-Rodriguez EM, Sole-Agusti MC, Taltavull-Aparicio JM, Vidal-Thomas MC, Gonzalez-Chorda VM; Cuidamos+75 Group. Impact of the COVID-19 pandemic on the self-care and health condition of the older adults. CUIDAMOS+75. A mixed methods study protocol. Front Public Health. 2024 Jun 17;12:1389641. doi: 10.3389/fpubh.2024.1389641. eCollection 2024.

Reference Type DERIVED
PMID: 38952731 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI21_00190

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

PI21_00648

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

PI21_CIII00015

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

20210009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sumamos Excelencia 2022
NCT05466656 ACTIVE_NOT_RECRUITING NA
One-4-ALL Initiative
NCT05454969 RECRUITING NA